Molecular Formula | C15H24N2O7S |
Molar Mass | 376.43 |
Density | 1.367±0.06 g/cm3(Predicted) |
Melting Point | 233-235°C dec. |
Boling Point | 714.9±60.0 °C(Predicted) |
Solubility | Soluble in DMSO (up to 20 mg/ml), in Water (up to 10 mg/ml), or in Ethanol (up to 1 mg/ml). |
Appearance | White to off-white powder |
Color | White to off-white |
pKa | 3.11±0.10(Predicted) |
Storage Condition | -20°C |
Stability | Stable for 2 years from date of purchase as supplied. Solutions in DMSO or ethanol may be stored at -20° for up to 1 month. Solutions in water are not stable and must be used with one working day. |
In vivo study | Lactacystin (microinjection; 2 µg) induces a Parkinson’s disease-like motor phenotype 5-7 days after injection in young and adult mice. Animal Model: Male C57Bl/6RccHsd mice with 8-9 weeks (young) and 12-14 months (adult) old Dosage: 2 µg Administration: Microinjection Result: Induced a Parkinson’s disease-like motor phenotype 5-7 days after injection in young and adult mice. |
WGK Germany | 3 |
Reference Show more | 1. [IF=10.392] Haoran Wei et al."KDELR2 promotes breast cancer proliferation via HDAC3-mediated cell cycle progression."Cancer Commun. 2021 Sep;41(9):904-920 |